Literature DB >> 23833693

Age-Dependent Resistance to Excitotoxicity in Htt CAG140 Mice and the Effect of Strain Background.

Melissa K Strong1, Amber L Southwell, Jennifer M Yonan, Michael R Hayden, Grant R Macgregor, Leslie M Thompson, Oswald Steward.   

Abstract

Mouse strain background can influence vulnerability to excitotoxic neuronal cell death and potentially modulate phenotypes in transgenic mouse models of human disease. Evidence supports a contribution of excitotoxicity to the selective death of medium spiny neurons in Huntington's disease (HD). Here, we assess whether strain differences in excitotoxic vulnerability influence striatal cell death in a knock-in mouse model of HD. Previous studies that evaluated resistance to excitotoxic lesions in several mouse models of HD had variable outcomes. In the present study, we directly compare one model on two different background strains to test the contribution of strain to excitotoxicity-mediated neurodegeneration. Mice of the FVB/N strain, which are highly vulnerable to excitotoxicity, become extremely resistant to quinolinic acid-induced striatal neurodegeneration with age, when carrying a huntingtin (Htt) allele expressing a HD transgene (CAG140). The resistance is much greater than the age-dependent resistance that has been previously reported in YAC128 mice. By 12 months of age, both heterozygous and homozygous FVB.CAG140 mice displayed virtually complete resistance to quinolinic acid-induced striatal neurodegeneration. A similar resistance develops in CAG140 mice on a C57BL/6N background although the effect size is smaller because C57BL/6N mice are already resistant due to genetic background. In a direct comparison with the YAC128 mice, FVB.CAG140 mice have greater resistance. FVB.CAG140 mice are also resistant to neurodegeneration following kainic acid-induced status epilepticus suggesting the existence of a common cellular mechanism that provides protection against multiple types of excitotoxic insult. These findings establish FVB.CAG140 mice as a useful model to investigate the cellular and molecular mechanisms that confer neuroprotection against excitotoxicity.

Entities:  

Keywords:  Excitotoxin; Huntington’s disease; cell death; genetic background; inbred mouse strains; neurodegeneration; resistance

Mesh:

Substances:

Year:  2012        PMID: 23833693      PMCID: PMC3702054          DOI: 10.3233/JHD-129005

Source DB:  PubMed          Journal:  J Huntingtons Dis        ISSN: 1879-6397


  63 in total

1.  Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates.

Authors:  E E Wanker; E Scherzinger; V Heiser; A Sittler; H Eickhoff; H Lehrach
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  Wild-type huntingtin protects neurons from excitotoxicity.

Authors:  Blair R Leavitt; Jeremy M van Raamsdonk; Jacqueline Shehadeh; Herman Fernandes; Zoe Murphy; Rona K Graham; Cheryl L Wellington; Lynn A Raymond; Michael R Hayden
Journal:  J Neurochem       Date:  2006-01-17       Impact factor: 5.372

3.  Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches.

Authors:  P E Schauwecker; O Steward
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

Authors:  L Mangiarini; K Sathasivam; M Seller; B Cozens; A Harper; C Hetherington; M Lawton; Y Trottier; H Lehrach; S W Davies; G P Bates
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

5.  A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.

Authors:  J G Hodgson; N Agopyan; C A Gutekunst; B R Leavitt; F LePiane; R Singaraja; D J Smith; N Bissada; K McCutcheon; J Nasir; L Jamot; X J Li; M E Stevens; E Rosemond; J C Roder; A G Phillips; E M Rubin; S M Hersch; M R Hayden
Journal:  Neuron       Date:  1999-05       Impact factor: 17.173

Review 6.  The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.

Authors:  Jia Yi Li; Natalija Popovic; Patrik Brundin
Journal:  NeuroRx       Date:  2005-07

7.  Genes on distal chromosome 18 determine vulnerability to excitotoxic neurodegeneration following status epilepticus, but not striatal neurodegeneration induced by quinolinic acid.

Authors:  Jessica Pilar McLin; Leslie Michels Thompson; Aldons J Lusis; Richard C Davis; Oswald Steward
Journal:  Neurobiol Dis       Date:  2007-10-11       Impact factor: 5.996

8.  Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.

Authors:  Elizabeth J Slow; Rona K Graham; Alexander P Osmand; Rebecca S Devon; Ge Lu; Yu Deng; Jacqui Pearson; Kuljeet Vaid; Nagat Bissada; Ronald Wetzel; Blair R Leavitt; Michael R Hayden
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-02       Impact factor: 11.205

9.  Pattern of neuronal death in the rat hippocampus after status epilepticus. Relationship to calcium binding protein content and ischemic vulnerability.

Authors:  T F Freund; A Ylinen; R Miettinen; A Pitkänen; H Lahtinen; K G Baimbridge; P J Riekkinen
Journal:  Brain Res Bull       Date:  1992-01       Impact factor: 4.077

10.  Neuronal activity up-regulates astroglial gene expression.

Authors:  O Steward; E R Torre; R Tomasulo; E Lothman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

View more
  4 in total

1.  Transgene expression in the Nop-tTA driver line is not inherently restricted to the entorhinal cortex.

Authors:  Michael J Yetman; Sveinung Lillehaug; Jan G Bjaalie; Trygve B Leergaard; Joanna L Jankowsky
Journal:  Brain Struct Funct       Date:  2015-04-14       Impact factor: 3.270

2.  An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes.

Authors:  Amber L Southwell; Amy Smith-Dijak; Chris Kay; Marja Sepers; Erika B Villanueva; Matthew P Parsons; Yuanyun Xie; Lisa Anderson; Boguslaw Felczak; Sabine Waltl; Seunghyun Ko; Daphne Cheung; Louisa Dal Cengio; Ramy Slama; Eugenia Petoukhov; Lynn A Raymond; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2016-07-04       Impact factor: 6.150

3.  Antagonistic pleiotropy in mice carrying a CAG repeat expansion in the range causing Huntington's disease.

Authors:  A J Morton; E A Skillings; N I Wood; Z Zheng
Journal:  Sci Rep       Date:  2019-01-10       Impact factor: 4.379

4.  Circadian dysfunction in response to in vivo treatment with the mitochondrial toxin 3-nitropropionic acid.

Authors:  Takashi Kudo; Dawn H Loh; Yu Tahara; Danny Truong; Elizabeth Hernández-Echeagaray; Christopher S Colwell
Journal:  ASN Neuro       Date:  2014-01-13       Impact factor: 4.146

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.